Simultaneous determination of arctiin and its metabolites in rat urine and feces by HPLC

Fitoterapia

Volumn 86, Issue 1, 2013, Pages 6-12

  Wang, Wei ^a   Pan, Qiang ^b   Han, Xue Ying ^a   Wang, Jing ^a   Tan, Ri Qiu ^a   He, Fan ^a   Dou, De Qiang ^a   Kang, Ting Guo ^a  

^a LIAONING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Liaoning Provincial Institute for Drug and Food Control   (China)

Author keywords

Arctiin; Excretion; Feces; HPLC; Metabolite; Urine

Indexed keywords

2 (3' HYDROXYBENZYL) 3 (3'',4'' DIMETHOXYBENZYL)BUTYROLACTONE; ARCTIGENIN; ARCTIIN; DRUG METABOLITE; ENTEROLACTONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EXCRETION; DRUG FECES LEVEL; DRUG METABOLISM; DRUG STABILITY; DRUG STRUCTURE; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

4-BUTYROLACTONE; ANIMALS; ARCTIUM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FECES; FRUIT; FURANS; GLUCOSIDES; LIGNANS; MALE; PLANT EXTRACTS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84876375739     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2013.01.016     Document Type: Article

References (24)

1. State Pharmacopoeia Committee Pharmacopoeia of the People's Republic of China (Part I) 1st ed. 2010 Chinese medicine Science and Technology Press Beijing 66 67
2. S. Lee, S. Shin, H. Kim, S. Han, K. Kim, and J. Kwon Anti-inflammatory function of arctiin by inhibiting COX-2 expression via NF-kB pathways J Inflamm 8 2011 16
3. S. Lwakami, J.B. Wu, Y. Ebizuka, and U. Sankawa Platelet activating factor (PAF) antagonists contained in medicinal plant: lignan and sesquiterpenes Chem Pharm Bull 40 1992 1196 1198
4. 2 + activity of lignans Chem Pharm Bull 34 1992 3514 3517
5. M. Hirose, T. Yamaguchi, C. Lin, N. Kimoto, M. Futakuchi, and T. Kono Effects of arctiin on PhIP-induced mammary, colon and pancreatic carcinogenesis in female Sprague-Dawley rats and MeIOx-induced hepatocarcinogenesis in male F344 rats Cancer Lett 155 2000 79 88
6. M.K. Cho, J.W. Park, Y.P. Jang, Y.C. Kim, and S.G. Kim Potent inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by dibenzylbutyrolactone lignans through inhibition of I-kappa B alpha phosphorylation and of p65 nuclear translocation in macrophages Int Immunol 2 2002 105 116
7. D.C. Ayres, and J.D. Loike Lignan chemical, biological and clinical properties 1st ed. 1990 Cambridge University Press Cambridge 117 130
8. J.G. Wu, J.Z. Wu, L.N. Sun, T. Han, J. Du, and Q. Ye Ameliorative effects of arctiin from Arctium lappa on experimental glomerulonephritis in rats Phytomedicine 16 2009 1033 1041
9. L.C. Lu, W. Zhou, Z.H. Li, C.P. Yu, C.W. Li, and M.H. Luo Effects of arctiin on streptozotocin-induced diabetic retinopathy in Sprague-Dawley rats Planta Med 78 2012 1317 1323
10. J. Lin, L. Yao, and M. Lame The increased emphasis of ADME properties in hit-to-lead drug discovery Acta Pharmacol Sin 8 2006 328 329
11. F. He, D.Q. Dou, Y. Sun, L. Zhu, H.B. Xioa, and T.G. Kang Plasma pharmacokinetics and tissue distribution of arctiin and its main metabolite in rats by HPLC-UV and LC-MS Planta Med 78 2012 800 806
12. S. Heinonen, T. Nurmi, K. Liukkonen, K. Poutanen, K. Wahala, and T. Deyama In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol J Agric Food Chem 49 2001 3178 3186
13. L.H. Xie, E.M. Ahn, T. Akao, A.A. Abdel-Hafez, N. Nakamura, and M. Hattori Transformation of arctiin to estrogenic and antiestrogenic substances by human intestinal bacteria Chem Pharm Bull 51 2003 378 384
14. M. Axelson, J. Sjövall, B.E. Gustafsson, and K.D.R. Setchell Origin of lignans in mammals and identification of a precursor from plants Nature 298 1982 659 660
15. N.M. Saarinen, A. Warri, S.I. Makela, C. Eckerman, M. Reunanen, and M. Ahotupa Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies) Nutr Cancer 36 2000 207 216
16. S. Heinonen, T. Nurmi, K. Liukkonen, K. Poutanen, K. Wähä lä, and T. Deyama In vitro metabolism of lignans: new precursors of mammalian lignans enterolactone and enterodiol J Agric Food Chem 49 2001 3178 3186
17. J.L. Peñalvo, S.M. Heinonen, A.M. Aura, and H. Adlercreutz Dietary sesamin is converted to enterolactone in humans J Nutr 135 2005 1056 1062
18. Z. Liu, N.M. Saarinen, and L.U. Thompson Sesamin is one of the major precursors of mammalian lignans in sesame seed (Seasmum indicum) in vitro and in rats J Nutr 136 2006 906 9012
19. N.M. Saarinen, R. Huovinen, A. Wärri, S.I. Mäkelä, L. Valentín-Blasini, and R. Sjöholm Enterolactone inhibits the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinomas in the rat Mol Cancer Ther 1 2002 869 876
20. D.M. Huang, Y.C. Shen, C. Wu, Y.T. Huang, F.L. Kung, and C.M. Teng Investigation of extrinsic and intrinsic apoptosis pathways of new clerodane diterpenoids in human prostate cancer PC-3 cells Eur J Pharmacol 503 2004 17 24
21. N.M. Saarinen, A. Smeds, S.I. Mäkelä, J. Ämmälä, K. Hakala, and J.M. Pihlava Structural determinants of plant lignans for the formation of enterolactone in vivo J Chromatogr B 777 2002 311 319
22. A.I. Smeds, N.M. Saarinen, T.T. Hurmerinta, P.E. Penttinen, R.E. Sjöholm, and S.I. Mäkelä Urinary excretion of lignans after administration of isolated plant lignans to rats: the effect of single dose and ten-day exposures J Chromatogr B 813 2004 303 312
23. M. Nose, T. Fujimoto, T. Takeda, S. Nishibe, and Y. Ogihara Structural transformation of lignan compounds in rat gastrointestinal tract Planta Med 58 1992 520 523
24. M. Nose, T. Fujimoto, S. Nishibe, and Y. Ogihara Structural transformation of lignan compounds in rat gastrointestinal tract (II) Planta Med 59 1993 131 134